6
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12004 |
Meropenem trihydrate
美罗培南三水合物,SM 7338 trihydrate |
Antibacterial; Antibiotic | Microbiology/Virology |
Meropenem trihydrate (SM 7338 trihydrate) 是一种碳青霉烯抗生素,具有广谱抗菌活性。它对敏感和耐药的杜克氏杆菌 (MIC 值为 0.015-0.12 mg/mL), 淋病奈瑟氏球菌 (MIC 值为 0.02-0.06 mg/mL)和流感嗜血杆菌 (MIC 值为 0.03-0.12 mg/mL) 具有活性。 | |||
T0868L | Cefepime | ||
Cefepime is an antibiotic. Cefepime has been shown to be effective against febrile neutropenia. | |||
T69516 | Thenalidine tartrate | ||
Thenalidine is an antihistamine with anticholinergic properties used as an antipruritic drug. It was withdrawn from the US, Canadian, and UK markets due to a risk of neutropenia. Thenalidine is an antagonist of the H1-receptor. | |||
T61581 | LasR-IN-2 | ||
LasR-IN-2, a compound that inhibits the activity of LasR, forms hydrogen bonding with the TRY-56 residue. It finds application in the study of bacterial infection, neutropenia, severe burns, and chronic lung disease in cystic fibrosis (CF) [1]. | |||
T77172 | Eflapegrastim | ||
Eflapegrastim 是一种人源化IgG4单抗 ,也是一种粒细胞集落刺激因子 (G-CSF)。Eflapegrastim 靶向G-CSF 受体 (c-Fms)。Eflapegrastim 刺激中性粒细胞祖细胞的增殖和分化,维持成熟和功能性中性粒细胞数目稳定。Eflapegrastim 还缩短中性粒细胞减少的持续时间。 | |||
T14493 |
Balapiravir
R1626,Ro 4588161 |
Others | Others |
Balapiravir (R1626, Ro 4588161) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479). IC50 Value: Target: HCV Balapiravir was discontinued for safety reasons in 28-36% of patients (m |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0224 |
Meropenem
美罗培南,SM 7338 |
Others; Antibacterial; Antibiotic | Microbiology/Virology; Others |
Meropenem (SM 7338) 是一种具有广谱抗菌活性的碳青霉烯抗生素,对敏感和耐药的淋病奈瑟氏球菌,流感嗜血杆菌和杜克氏杆菌的 MIC 值分别为 0.02-0.06 mg/mL,0.03-0.12 mg/mL 和 0.015-0.12 mg/mL。 |